Precision medicine for pancreatic cancer: Characterizing the clinico-genomic landscape and outcomes of KRAS G12C-mutated disease.
Keane F, Chou JF, Walch H, Schoenfeld J, Singhal A, Cowzer D, Harrold E, O'Connor C, Park W, Varghese A, El Dika I, Balogun F, Yu KH, Capanu M, Schultz N, Yaeger R, O'Reilly EM.
Keane F, et al. Among authors: singhal a.
J Natl Cancer Inst. 2024 May 3:djae095. doi: 10.1093/jnci/djae095. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 38702822